Key Segmentation
By RNA Type
-
mRNA Therapeutics & Vaccines
-
siRNA Therapeutics
-
ASO, circRNA & Other RNA Modalities
By Service Type
-
Process Development & Analytical Services
-
Clinical Manufacturing
-
Commercial Manufacturing & Fill-Finish
By Application
-
Infectious Diseases
-
Oncology
-
Rare Diseases & Genetic Disorders
-
Others
By End User
-
Biopharmaceutical Companies
-
Academic & Research Institutes
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The RNA Therapeutics CDMO Market was valued at USD 15.80 Billion in 2025.
The market is projected to reach USD 40.68 Billion by 2035.
The market is expected to expand at a CAGR of 9.86% during the forecast period.
North America dominated the global market with a 46.00% revenue share in 2025.
mRNA Therapeutics & Vaccines accounted for the largest revenue share of 48.00% in 2025.